Early mortality and cause of deaths in patients using HAART in Brazil and the United States

Dore, 2002, Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia, J Acquir Immune Defic Syndr, 29, 388, 10.1097/00126334-200204010-00010

Egger, 2002, Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, Lancet, 360, 119, 10.1016/S0140-6736(02)09411-4

Hogg, 2001, Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy, JAMA, 286, 2568, 10.1001/jama.286.20.2568

Lee, 2001, Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984–1997, JAMA, 285, 1308, 10.1001/jama.285.10.1308

Braitstein, 2006, Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, 367, 817, 10.1016/S0140-6736(06)68337-2

Campos, 2005, Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986–2003, AIDS, 19, S22, 10.1097/01.aids.0000191486.92285.1c

Coetzee, 2004, Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa, AIDS, 18, 887, 10.1097/00002030-200404090-00006

Grinsztejn, 2007, Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil, J Acquir Immune Defic Syndr, 45, 515, 10.1097/QAI.0b013e3180decb6a

Wester, 2005, Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana, J Acquir Immune Defic Syndr, 40, 336, 10.1097/01.qai.0000159668.80207.5b

Rosen, 2007, Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review, PLoS Med, 4, 1691, 10.1371/journal.pmed.0040298

Moore, 1998, Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort, J Acquir Immune Defic Syndr Hum Retrovirol, 17, S38, 10.1097/00042560-199801001-00011

Lucas, 2006, Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy, Am J Epidemiol, 163, 412, 10.1093/aje/kwj059

Moh, 2007, Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa, AIDS, 21, 2483, 10.1097/QAD.0b013e3282f09876

Etard, 2006, Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, 20, 1181, 10.1097/01.aids.0000226959.87471.01

Lawn, 2005, Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme, AIDS, 19, 2050, 10.1097/01.aids.0000191232.16111.f9

Saraceni, 2008, Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil, Int J Tuberc Lung Dis, 12, 769

Getahun, 2007, Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes, Lancet, 369, 2042, 10.1016/S0140-6736(07)60284-0

Moore, 2007, Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda, AIDS, 21, 713, 10.1097/QAD.0b013e328013f632

Wood, 2007, Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control, Am J Respir Crit Care Med, 175, 87, 10.1164/rccm.200606-759OC

Lawn, 2005, Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design, AIDS, 19, 2141, 10.1097/01.aids.0000194802.89540.e1

Dromer, 2007, Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study, PLoS Med, 4, 297, 10.1371/journal.pmed.0040021

Jarvis, 2009, Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa, Clin Infect Dis, 48, 856, 10.1086/597262

Lawn, 2007, Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa, AIDS, 21, 335, 10.1097/QAD.0b013e328011efac

Girardi, 2007, Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing, J Acquir Immune Defic Syndr, 46, S3, 10.1097/01.qai.0000286597.57066.2b

Souza-Jr, 2007, Delay in introducing antiretroviral therapy in patients infected by HIV in Brazil, 2003–2006, Clinics, 62, 579, 10.1590/S1807-59322007000500008